NCT06857240: An ongoing trial by The Cleveland Clinic
This trial is ongoing. It must report results 1 year, 6 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06857240 |
|---|---|
| Title | Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 1, 2025 |
| Completion date | Dec. 31, 2026 |
| Required reporting date | Dec. 31, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | June 24, 2026 |
| Days late | None |